Panic disorder is an anxiety condition defined by recurrent, unexpected panic attacks followed by at least one month of persistent concern about future attacks, significant worry about their implications, or maladaptive behavioral changes resulting from them.

An estimated 2.7% of U.S. adults experience panic disorder in any given year — 3.8% of women and 1.6% of men — with a lifetime prevalence of 4.7% (NIMH, NCS-R). Of those affected, nearly 45% experience serious functional impairment and only 25.7% have mild impairment (NIMH) — making panic disorder one of the more disabling anxiety conditions when left untreated. The good news is that it responds well to evidence-based treatment, particularly cognitive behavioral therapy and SSRI medications.

Key Takeaways:

• Panic disorder ≠ panic attacks — isolated panic attacks are common; panic disorder requires persistent worry, fear of recurrence, or behavior change lasting at least one month after an attack.
• Women are affected at more than twice the rate of men — past-year prevalence is 3.8% in women vs. 1.6% in men (NIMH).
• Agoraphobia frequently develops as a consequence — avoidance behaviors that begin as attempts to prevent attacks can escalate into significant restrictions on daily movement and activity.
• Depression co-occurs in approximately one-third of cases — the two conditions reinforce each other and require concurrent treatment for the best outcomes.
• CBT is the primary evidence-based treatment — it is more cost-effective than medication, associated with lower relapse rates, and effective even when delivered as guided self-help.
• SSRIs (sertraline, escitalopram) are first-line medications — they carry the highest remission rates and lowest adverse event profiles among pharmacological options.
• Combined CBT and antidepressants outperforms either alone in the short term, particularly when agoraphobia or depression is present.

What Is Panic Disorder?

Panic disorder is a DSM-5 anxiety disorder characterized by recurrent unexpected panic attacks — abrupt surges of intense fear or discomfort that peak within minutes — combined with at least one month of consequential psychological or behavioral response. The condition is formally classified in the DSM-5 (code 300.01) and ICD-11 (code 6B01); both require that the disorder not be attributable to substances, medications, or another medical condition.

A single panic attack, while distressing, does not constitute panic disorder. Panic disorder is diagnosed when attacks are followed by persistent concern about additional attacks, worry about what the attacks mean (losing control, having a heart attack, “going crazy”), or significant maladaptive behavioral changes — such as avoiding exercise or unfamiliar places — lasting at least one month (PMC, 2019). This distinction between the attack itself and the disorder that follows is clinically essential.

Panic disorder carries a chronic course when untreated, with substantial impact on quality of life, work, and relationships. Patients with panic disorder have a high use of medical services and impaired social and occupational functioning; about one-third of patients with depression also present with panic disorder, reflecting the close and bidirectional relationship between the two conditions (PMC, 2006).

Panic Attack vs. Panic Disorder: What Is the Difference?

A panic attack is a discrete event — an abrupt surge of intense fear that peaks within minutes, involving physical and cognitive symptoms. A panic disorder is a clinical condition that develops when attacks recur unexpectedly and produce lasting psychological consequences. Panic attacks can occur in the context of many mental health conditions — including PTSD, social anxiety disorder, and specific phobias — and do not by themselves indicate panic disorder.

Feature	Panic Attack vs. Panic Disorder
Panic attack	A single episode of abrupt, intense fear peaking within minutes; can occur in anyone; does not require clinical diagnosis or treatment on its own
Panic disorder	A pattern of recurrent unexpected attacks plus at least one month of anticipatory anxiety, fear about implications, or behavioral avoidance — this requires formal diagnosis and treatment
Expected vs. unexpected	Panic disorder attacks are unexpected — they arise without an obvious trigger; expected attacks (e.g., from a known phobia) may not meet criteria even if the symptoms are identical
With vs. without agoraphobia	DSM-5 separates panic disorder and agoraphobia into independent diagnoses; agoraphobia can co-occur with panic disorder or occur independently

Symptoms of a Panic Attack

DSM-5 defines a panic attack as an abrupt surge of intense fear or discomfort reaching peak intensity within minutes, during which four or more of the following 13 symptoms occur. These symptoms are divided into physical (somatic) and cognitive categories.

Physical (Somatic) Symptoms

• Palpitations, pounding heart, or accelerated heart rate
• Sweating
• Trembling or shaking
• Shortness of breath or feeling smothered
• Feelings of choking
• Chest pain or discomfort
• Nausea or abdominal distress
• Dizziness, unsteadiness, lightheadedness, or faintness
• Chills or hot flashes
• Paresthesias — numbness or tingling sensations

Cognitive Symptoms

• Derealization — feelings of unreality, as if surroundings are not real
• Depersonalization — feeling detached from oneself
• Fear of losing control or “going crazy”
• Fear of dying

The intense physical symptoms — particularly rapid heart rate, chest pain, and shortness of breath — frequently cause people to seek emergency care, believing they are having a heart attack. This is one of the primary reasons panic disorder is both underdiagnosed and expensive to the healthcare system; extensive cardiac and medical workups often return normal results before a mental health evaluation occurs.

Panic Disorder and Agoraphobia

Agoraphobia is a distinct DSM-5 diagnosis characterized by intense fear or anxiety about situations where escape might be difficult or help unavailable during a panic attack — including being outside the home alone, in crowds, on public transport, in open or enclosed spaces, or standing in line. Most patients with panic disorder avoid situations where they believe a panic attack may occur, and avoidance may severely restrict their life (PMC, 2006).

The DSM-5 decoupled panic disorder and agoraphobia in 2013 — they are now separate diagnoses that can co-occur. Panic disorder in Europe has a one-year prevalence of 2–3%, with agoraphobia without panic occurring in an additional 1% of the population (PMC, 2006). When agoraphobia develops alongside panic disorder, it typically indicates more severe avoidance, greater functional impairment, and a stronger indication for combined CBT and pharmacotherapy rather than either alone.

Causes and Risk Factors for Panic Disorder

Panic disorder develops through a biopsychosocial model — the interaction of genetic vulnerability, neurobiological dysregulation, and environmental stressors. No single cause has been identified; the disorder is considered polygenic and multifactorial.

Risk Factor	What the Research Shows
Genetic predisposition	Panic disorder is a polygenic condition; family history significantly elevates risk, and twin studies show higher concordance in identical than fraternal twins, supporting a substantial hereditary component
Amygdala hyperreactivity	Dysfunctional cross-talk between the emotional drive of the limbic system and cognitive inhibition of the prefrontal cortex — the amygdala-hippocampal-prefrontal fear circuit — is considered the neuroanatomical basis of panic disorder (PMC, 2019); this circuit produces inappropriate alarm responses in the absence of real threat
Anxiety sensitivity	High anxiety sensitivity — the tendency to interpret physical sensations as dangerous — is a robust predictor of panic disorder development; individuals who catastrophize a racing heart or shortness of breath as signs of cardiac danger are at elevated risk
Life stressors and trauma	Major stressors — bereavement, relationship breakdown, job loss, medical illness — frequently precede first panic attacks in genetically vulnerable individuals; early adverse experiences and childhood trauma also increase susceptibility
Substance use	Stimulants, caffeine, cannabis, and cocaine can precipitate panic attacks; alcohol withdrawal is a common direct trigger; substance use disorders frequently co-occur with panic disorder
Medical conditions	Hyperthyroidism, cardiac arrhythmias, hypoglycemia, and respiratory disorders produce symptoms that overlap with panic attacks and require exclusion before a psychiatric diagnosis is confirmed
Sex	Past-year prevalence is more than twice as high in women (3.8%) as in men (1.6%), a disparity consistent with other internalizing anxiety disorders (NIMH)

Co-Occurring Conditions

Panic disorder rarely presents in isolation. It is associated with several psychiatric conditions, including depression and other anxiety disorders; about one-third of patients with depression also present with panic disorder (PMC, 2006). Identifying co-occurring conditions is clinically important because they influence treatment selection, severity, and prognosis.

Condition	Clinical Relationship
Major depressive disorder	Comorbid depression does not impede CBT treatment response; successful CBT reduces both panic and depressive symptoms concurrently (PMC, 2010)
Generalized anxiety disorder	Persistent worry frequently co-occurs with episodic panic; rates of comorbid GAD decline significantly after successful CBT for panic disorder
Social anxiety disorder	Fear of having a panic attack in social settings can drive avoidance that overlaps with social anxiety disorder; differential diagnosis guides treatment selection
Agoraphobia	A separate DSM-5 diagnosis that frequently co-occurs; presence indicates more severe avoidance and generally requires combined CBT and pharmacotherapy
Substance use disorders	Substance use both triggers panic attacks and develops as a coping strategy; alcohol and benzodiazepine misuse are particularly common and create dependency risk
PTSD	Differential diagnosis requires determining whether attacks are triggered by trauma cues (PTSD) or arise unexpectedly (panic disorder) — both conditions can co-occur

How Panic Disorder Is Diagnosed

Diagnosis requires a clinical interview conducted by a mental health professional, using DSM-5 criteria as the primary framework. The core diagnostic requirements are:

• Recurrent unexpected panic attacks (Criterion A)
• At least one attack followed by one month or more of: persistent concern about additional attacks, significant worry about what attacks mean (loss of control, heart attack, going crazy), or significant maladaptive behavioral change related to the attacks (Criterion B)
• The disturbance is not attributable to physiological effects of a substance or medical condition (Criterion C)
• The disturbance is not better explained by another mental disorder (Criterion D)

Medical evaluation is an essential first step — particularly to rule out hyperthyroidism, cardiac arrhythmias, hypoglycemia, and respiratory conditions that produce overlapping physical symptoms. Laboratory tests, electrocardiograms, and thyroid panels are used to exclude these conditions before a psychiatric diagnosis is finalized. Validated assessment tools — including the Panic Disorder Severity Scale (PDSS) and structured diagnostic interviews — provide systematic measurement of attack frequency, distress, and functional impairment.

Treatment for Panic Disorder

Panic disorder can be effectively treated with psychological treatments such as cognitive behavioral therapy and, where indicated, pharmacotherapy with SSRIs or SNRIs (PMC, 2019). Current guidelines recommend CBT as the primary first-line treatment; medication is recommended as an alternative first-line option or as an adjunct when CBT alone is insufficient.

Cognitive Behavioral Therapy (CBT)

CBT for panic disorder targets the catastrophic misinterpretation of bodily sensations that sustains panic attacks and anticipatory anxiety. CBT is more effective than waiting-list and other controls in reducing symptoms in panic disorder with or without mild to moderate agoraphobia, and evidence suggests its effects last longer than antidepressants alone after treatment discontinuation (PMC, 2010). The core components include:

• Psychoeducation — understanding the physiology of panic attacks defuses their perceived danger
• Cognitive restructuring — identifying and challenging catastrophic interpretations of physical sensations (“I’m having a heart attack” → “this is uncomfortable but not dangerous”)
• Interoceptive exposure — deliberately inducing feared physical sensations (e.g., spinning to produce dizziness) in a controlled setting to reduce sensitivity to them
• In vivo exposure — gradual, systematic confrontation of avoided situations when agoraphobia is present
• Breathing retraining — diaphragmatic breathing to counter hyperventilation during attacks
• Relapse prevention — identifying early warning signs and maintaining coping strategies post-treatment

Treatment typically spans 10–16 sessions. Guided self-help CBT delivered via the internet is equally effective to face-to-face CBT for panic disorder symptoms and comorbid anxiety and depression, making it a cost-effective first-line option for increasing treatment access (PMC, 2021).

Medications

SSRIs and SNRIs are the first-line pharmacological treatments. Benzodiazepines provide short-term relief but are associated with dependency risk and poorer long-term outcomes, and current guidelines recommend against their routine prescription for panic disorder.

Medication Class	Clinical Role
SSRIs (sertraline, escitalopram, paroxetine, fluoxetine)	Among SSRIs, sertraline and escitalopram are associated with high remission rates and low risk of adverse events and are considered the preferred SSRI options (PMC, 2022); full effects typically emerge over 4–6 weeks
SNRIs (venlafaxine)	First-line alternative to SSRIs; equivalent efficacy with a similar adverse event profile; recommended in current practice guidelines alongside SSRIs
TCAs (imipramine, clomipramine)	Effective but carry a significantly higher adverse event burden than SSRIs; generally reserved for cases where SSRIs and SNRIs fail
Benzodiazepines (alprazolam, clonazepam)	NICE guidelines conclude that benzodiazepines are associated with worse long-term outcomes and should not be routinely prescribed for panic disorder (PMC, 2006); short-term use may be appropriate in severe cases while first-line treatments take effect

Combined CBT and Medication

A Cochrane meta-analysis of 21 studies found that combined antidepressant and CBT treatment is more effective than either alone in the short term, particularly for panic disorder with agoraphobia; relapse after treatment discontinuation is more common with antidepressants alone than with CBT monotherapy (PMC, 2008). Combined treatment is preferred when agoraphobia, comorbid depression, or severe impairment is present.

Self-Management Strategies

Self-management strategies complement professional treatment and reduce panic attack severity when practiced consistently. These are evidence-informed techniques that work by counteracting the physiological and cognitive processes that sustain panic.

• Diaphragmatic breathing: Slow, deep belly breathing — inhaling for 4 counts, exhaling for 6 — activates the parasympathetic nervous system and directly counteracts the hyperventilation that intensifies panic symptoms
• Grounding (5-4-3-2-1): Name 5 things you can see, 4 you can hear, 3 you can touch, 2 you can smell, 1 you can taste — this anchors attention to the immediate environment and interrupts cognitive spirals
• Reducing avoidance: Gradually confronting feared situations prevents avoidance from escalating into agoraphobia; avoidance temporarily reduces anxiety but reinforces and sustains fear over time
• Limiting stimulants: Caffeine, nicotine, and energy drinks stimulate the sympathetic nervous system and lower the threshold for panic attacks
• Regular aerobic exercise: Aerobic exercise appears modestly effective for panic disorder (PMC, 2019) through its effects on sympathetic arousal, sleep quality, and mood regulation
• Consistent sleep: Sleep deprivation raises physiological arousal and lowers anxiety thresholds; a regular sleep schedule is a foundational component of anxiety management

Frequently Asked Questions About Panic Disorder

How do I know if I’m having a panic attack or a heart attack?

Panic attacks and cardiac events share symptoms — chest pain, rapid heart rate, shortness of breath, and dizziness — which is why many people with panic disorder first present to emergency departments. Key differences: panic attacks typically peak within minutes and resolve within 20–30 minutes; chest pain from panic is often sharp and positional rather than pressure-like; and panic attacks frequently include cognitive symptoms like derealization, fear of dying, or fear of losing control that are less typical of cardiac events. If there is any doubt, seek emergency medical evaluation — panic disorder should be diagnosed only after cardiac and medical causes have been excluded.

Can panic disorder go away on its own?

Panic disorder tends to follow a chronic, fluctuating course when untreated. Some individuals experience periods of remission, but without treatment the disorder typically persists and may worsen — particularly as avoidance behaviors develop and compound into agoraphobia. The good news is that short-term psychological interventions can improve the lives of most patients with panic disorder (PMC, 2006). Early treatment substantially improves prognosis.

Is panic disorder more common in women?

Yes — significantly so. Past-year prevalence is 3.8% in women and 1.6% in men, with the female-to-male ratio consistent across most international studies (NIMH). Among adolescents, the disparity is also present but smaller: 2.6% of female adolescents vs. 2.0% of male adolescents experience panic disorder in their lifetime. The reasons for the sex difference are not fully established but likely involve a combination of biological, hormonal, and psychosocial factors.

Does panic disorder cause agoraphobia?

Panic disorder does not directly cause agoraphobia — but agoraphobia commonly develops as a consequence of panic disorder when avoidance behaviors expand. People begin avoiding situations they associate with past attacks (crowded places, public transport, being alone outside), and that avoidance gradually generalizes. The DSM-5 now treats panic disorder and agoraphobia as separate diagnoses that can co-occur. When agoraphobia is present alongside panic disorder, combined CBT and antidepressant treatment is generally more effective than either approach alone.

Will I need medication long-term for panic disorder?

Not necessarily. CBT is associated with lower relapse rates than antidepressant monotherapy after treatment ends, making it the preferred stand-alone treatment when medication is not required (PMC, 2008). Many people achieve sustained remission through a time-limited course of CBT without ongoing medication. When medications are prescribed, they are typically maintained for 6–12 months after symptom remission before gradual tapering is considered. The decision depends on severity, comorbidities, and individual treatment response.

Can panic disorder co-occur with depression?

Yes, and the overlap is common. About a third of patients with depression also present with panic disorder (PMC, 2006). The two conditions reinforce each other — panic produces helplessness and avoidance that deepens depression, while depression lowers the threshold for anxiety responses. Importantly, comorbid depression does not impede CBT treatment response for panic disorder; successful CBT reduces both panic symptoms and comorbid depressive symptoms concurrently (PMC, 2010).

What is interoceptive exposure and why is it used in panic treatment?

Interoceptive exposure is a CBT technique in which patients deliberately induce the physical sensations they fear — spinning to cause dizziness, breathing through a straw to simulate breathlessness, running in place to elevate heart rate — in a controlled setting. The goal is to break the conditioned fear of these sensations by demonstrating they are uncomfortable but not dangerous. Through repeated exposure, anxiety sensitivity decreases: the racing heart loses its association with catastrophe, and the person gains tolerance for the sensations that previously triggered panic.

Summary: Panic disorder is a common, diagnosable, and highly treatable anxiety condition affecting approximately 2.7% of U.S. adults annually — characterized by recurrent unexpected panic attacks plus persistent anticipatory anxiety or behavioral avoidance — that responds well to CBT, SSRIs, or their combination, with CBT providing the most durable long-term outcomes.

Panic disorder is treatable, and with the right support most people achieve significant improvement. Worthy Wellness Center provides evidence-based mental health treatment for panic disorder and the co-occurring conditions — depression, anxiety, trauma, and substance use — that frequently accompany it. Contact Worthy Wellness Center to speak with their clinical team about a personalized treatment plan.